Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study
Iain B McInnes, Koji Kato, Marina Magrey, Joseph F Merola, Mitsumasa Kishimoto, César Pacheco-Tena, Derek Haaland, Liang Chen, Yuanyuan Duan, Patrick Zueger, John Liu, Ralph Lippe, Aileen L Pangan, Frank Behrens
RMD Open Oct 2021, 7 (3) e001838; DOI: 10.1136/rmdopen-2021-001838